LIGAND PHARMACEUTICALS INC
LGND
40 insider filings · Latest: Oct 2, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | Mar 6 11:49 PM | Octavio EspinozaChief Financial Officer | Sale | 13,423 | $205.83 | $2.8M | 21,662(D) | View → |
| Mar 6, 2026 | Mar 6 9:17 PM | JOHN L LAMATTINA | Proposed Sale | 2,161 | $200.76 | $433.8K | — | View → |
| Mar 3, 2026 | Mar 5 4:05 PM | Stephen L SabbaDirector | Sale | 2,034 | $201.50 | $409.9K | 33,793(D) | View → |
| Mar 2, 2026 | Mar 5 2:04 AM | John W KozarichDirector | Sale | 467 | $200.50 | $93.6K | 42,720(D) | View → |
| Mar 4, 2026 | Mar 4 9:44 PM | ANDREW REARDON | Proposed Sale | 20,000 | $204.24 | $4.1M | — | View → |
| Mar 4, 2026 | Mar 4 9:39 PM | OCTAVIO ESPINOZA | Proposed Sale | 13,423 | $204.24 | $2.7M | — | View → |
| Mar 3, 2026 | Mar 3 9:27 PM | STEPHEN L. SABBA | Proposed Sale | 2,034 | $201.50 | $409.9K | — | View → |
| Feb 2, 2026 | Feb 4 10:18 PM | John W KozarichDirector | Sale | 467 | $195.91 | $91.5K | 43,187(D) | View → |
| Feb 2, 2026 | Feb 2 9:12 PM | KOZARICH JOHN W | Proposed Sale | 467 | $192.18 | $89.7K | — | View → |
| Jan 2, 2026 | Jan 2 9:04 PM | KOZARICH JOHN W | Proposed Sale | 467 | $188.60 | $88.1K | — | View → |
| Dec 12, 2025 | Dec 12 10:22 PM | OCTAVIO ESPINOZA | Proposed Sale | 1,804 | $188.31 | $339.7K | — | View → |
| Dec 1, 2025 | Dec 1 9:08 PM | KOZARICH JOHN W | Proposed Sale | 467 | $199.88 | $93.3K | — | View → |
| Nov 7, 2025 | Nov 7 10:05 PM | NANCY GRAY | Proposed Sale | 6,571 | $205.45 | $1.4M | — | View → |
| Nov 7, 2025 | Nov 7 9:05 PM | JOHN L LAMATTINA | Proposed Sale | 4,179 | $205.45 | $858.6K | — | View → |
| Nov 3, 2025 | Nov 3 9:05 PM | KOZARICH JOHN W | Proposed Sale | 467 | $191.05 | $89.2K | — | View → |
| Oct 1, 2025 | Oct 1 8:09 PM | KOZARICH JOHN W | Proposed Sale | 467 | $176.68 | $82.5K | — | View → |
| Sep 23, 2025 | Sep 23 8:50 PM | JASON M ARYEH | Proposed Sale | 10,000 | $170.81 | $1.7M | — | View → |
| Sep 17, 2025 | Sep 17 4:41 PM | Aryeh Jason | Proposed Sale | 10,000 | $168.50 | $1.7M | — | View → |
| Sep 2, 2025 | Sep 2 8:16 PM | KOZARICH JOHN W | Proposed Sale | 467 | $161.71 | $75.5K | — | View → |
| Aug 1, 2025 | Aug 1 8:04 PM | KOZARICH JOHN W | Proposed Sale | 467 | $131.00 | $61.2K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 6, 2026 | Mar 31 9:53 PM | John L LamattinaDirector | Option Exercise | 2,161 | $114.15 | 0(D) | View → |
| Mar 2, 2026 | Mar 28 1:20 AM | Octavio EspinozaChief Financial Officer | Grant/Award | 23,527 | $202.55 | 23,527(D) | View → |
| Mar 2, 2026 | Mar 28 12:33 AM | Todd C DavisDirector, Chief Executive Officer | Grant/Award | 50,058 | $202.55 | 50,058(D) | View → |
| Mar 2, 2026 | Mar 28 12:16 AM | Andrew ReardonCLO & Secretary | Grant/Award | 21,525 | $202.55 | 21,525(D) | View → |
| Mar 11, 2026 | Mar 13 11:29 PM | Octavio EspinozaChief Financial Officer | Option Exercise | 2,405 | $92.65 | 0(D) | View → |
| Mar 4, 2026 | Mar 6 11:51 PM | Andrew ReardonCLO & Secretary | Option Exercise | 5,000 | $52.27 | 54,444(D) | View → |
| Mar 4, 2026 | Mar 6 11:49 PM | Octavio EspinozaChief Financial Officer | Option Exercise | 2,073 | $80.72 | 0(D) | View → |
| Mar 3, 2026 | Mar 5 4:05 PM | Stephen L SabbaDirector | Option Exercise | 2,034 | $69.51 | 0(D) | View → |
← Previous
Page 2 of 2